Research Briefs
Date of this Version
4-1-2016
Abstract
Medicare Part D beneficiaries with higher out-of-pocket costs are more likely to delay starting or not start a recommended specialty drug when newly diagnosed with leukemia. Policy changes are needed to ensure optimal access to specialty medications under Medicare Part D.
Document Type
Brief
Number
13
License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 License.
Keywords
health insurance, medicare
View On LDI Website
http://ldi.upenn.edu/brief/high-cost-sharing-and-specialty-drug-initiation-under-medicare-part-d-case-study-patients
Date Posted: 09 December 2016